Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/digital-migraine-treatment-device-market Download Exclusive Sample Report:https://www.datamintelligence.com/download-sample/digital-migraine-treatment-device-market Browse in-depth TOC on "Digital Migraine Treatment Device Market"  70 – Tables 66 – Figures 195 – Pages Market Segmentation Analysis By Type By Application Hospitals remained the leading end-user in 2024, generating...

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/digital-migraine-treatment-device-market

Browse in-depth TOC on "Digital Migraine Treatment Device Market" 

70 – Tables
66 – Figures
195 – Pages

Market Segmentation Analysis

By Type

By Application

Hospitals remained the leading end-user in 2024, generating revenues of over USD 55 million, as clinicians prescribe devices alongside standard migraine care. Specialty Clinics, focused on neurology and pain management, contributed USD 45 million, reflecting growing physician confidence in device efficacy. Other settings (including telemedicine channels and direct-to-consumer models) generated USD 20 million but are expected to expand rapidly with the rise of digital health adoption.

Request for Customized Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/digital-migraine-treatment-device-market

Regional Insights: USA & Japan

United States

The U.S., valued at USD 68 million in 2024, dominates the global market due to:

Japan

Japan's market, valued at USD 11 million in 2024, is expanding at a faster pace relative to other Asia-Pacific nations. Growth drivers include:

Industry Trends & Recent Developments

Competitive Landscape: Key Players

Cefaly Technology

The pioneer in supraorbital stimulation devices, Cefaly reported USD 40 million in 2024 revenues. Its strong brand recognition and recent integration with smartphone platforms make it the market leader in digital migraine therapy.

ElectroCore, Inc.

ElectroCore's gammaCore VNS device generated USD 28 million in revenues in 2024, with FDA clearances for multiple headache disorders. In 2025, it expanded into telemedicine partnerships to improve distribution in rural U.S. markets.

eNeura Inc.

Focused on sTMS devices, eNeura generated USD 20 million in revenues in 2024. The company is exploring partnerships with Japanese hospitals to strengthen its Asia-Pacific footprint.

Theranica Bio-Electronics LTD

Theranica's Nerivio wearable device achieved strong adoption, with USD 15 million revenues in 2024. Its app-based platform and AI integration differentiate it as a next-gen digital therapy.

Salvia BioElectronics & Neurolief Ltd.

These firms are advancing breakthrough devices in ONS and multi-target neuromodulation, with several late-stage clinical trials underway in 2025. Their progress could expand the therapeutic arsenal in migraine management.

Buy This Exclusive Report at Just USD 4350 Only: https://www.datamintelligence.com/buy-now-page?report=digital-migraine-treatment-device-market

Strategic Outlook

The Digital Migraine Treatment Devices Market is set for rapid expansion over the next decade. The market's growth trajectory highlights three defining imperatives:

Conclusion

The global Digital Migraine Treatment Devices Market, projected to rise from USD 119.71 million in 2024 to USD 298.71 million by 2030, reflects a decisive shift toward non-invasive, patient-friendly migraine solutions. With the U.S. driving clinical adoption and Japan setting innovation benchmarks in Asia, stakeholders across medtech, digital health, and investment ecosystems have a compelling growth opportunity.

Related Reports:

Request for Trial Access of AI-Driven Database Subscription Platform: https://www.datamintelligence.com/reports-subscription 

Features of AI-Driven DataM Insights Database Subscription:

Track all your competitors in one centralized dashboard – From R&D, Investment, to marketing strategies, track your global and regional rivals with ease.

Competitive Intelligence – Stay ahead with detailed company profiling, SWOT analyses, and sales performance tracking.

Curated Industry News – Daily alerts keep teams informed about product innovation, M&A activity, and competitor moves.

Instant Report Access – Access the complete library of market reports across geographies.

Customizations Free of Charge – Get specific segments or competitor data added without paying extra.

Regional and Country-Level Insights – Get detailed views of market trends across the U.S., EU5, Japan, India, and LATAM.

Live Import/Export Data Access – Make informed decisions using real-time trade intelligence.

Contact:

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: [email protected]

Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/digital-migraine-treatment-devices-market-to-reach-usd-298-71-million-by-2030--fueled-by-non-invasive-neuromodulation-and-expanding-clinical-adoption--datam-intelligence-302565809.html